Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

Stage IV Gastric Cancer With Metastasis Clinical Trial

Official title:
Prospective and Non-interventional Study on Peritoneal Metastasis of Stage IV Gastric Cancer

Status Active, not recruiting

Clinical Trial Summary

This is a non-interventional study，aim to observe the safety and efficiency of different treatment regimen for peritoneal metastasis of Stage IV gastric cancer in the real world

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Neoplasm Metastasis
Stage IV Gastric Cancer With Metastasis
Stomach Neoplasms

Clinical Trial Details

NCT number	NCT03237507
Study type	Observational
Source	Harbin Medical University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 1, 2017
Completion date	June 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01964027` - The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer	Phase 2
Recruiting	`NCT03604614` - Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal Metastatis	Phase 2
Not yet recruiting	`NCT05441254` - Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study	Phase 2
Completed	`NCT01525771` - Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer	Phase 1/Phase 2
Completed	`NCT01503983` - Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive	Phase 2